175 related articles for article (PubMed ID: 37978838)
41. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.
Albuquerque PC; Fonseca FL; Dutra FF; Bozza MT; Frases S; Casadevall A; Rodrigues ML
Future Microbiol; 2014; 9(2):147-61. PubMed ID: 24571070
[TBL] [Abstract][Full Text] [Related]
42. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.
Nimrichter L; Frases S; Cinelli LP; Viana NB; Nakouzi A; Travassos LR; Casadevall A; Rodrigues ML
Eukaryot Cell; 2007 Aug; 6(8):1400-10. PubMed ID: 17573547
[TBL] [Abstract][Full Text] [Related]
43. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
Mukherjee J; Scharff MD; Casadevall A
Infect Immun; 1995 Sep; 63(9):3353-9. PubMed ID: 7642262
[TBL] [Abstract][Full Text] [Related]
44. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.
McFadden DC; Fries BC; Wang F; Casadevall A
Eukaryot Cell; 2007 Aug; 6(8):1464-73. PubMed ID: 17601878
[TBL] [Abstract][Full Text] [Related]
45. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.
Kozel TR; Levitz SM; Dromer F; Gates MA; Thorkildson P; Janbon G
Infect Immun; 2003 May; 71(5):2868-75. PubMed ID: 12704160
[TBL] [Abstract][Full Text] [Related]
46. Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages.
Chang ZL; Netski D; Thorkildson P; Kozel TR
Infect Immun; 2006 Jan; 74(1):144-51. PubMed ID: 16368967
[TBL] [Abstract][Full Text] [Related]
47. Analysis of CAR-Mediated Tonic Signaling.
Calderon H; Mamonkin M; Guedan S
Methods Mol Biol; 2020; 2086():223-236. PubMed ID: 31707680
[TBL] [Abstract][Full Text] [Related]
48. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction.
McFadden DC; De Jesus M; Casadevall A
J Biol Chem; 2006 Jan; 281(4):1868-75. PubMed ID: 16278213
[TBL] [Abstract][Full Text] [Related]
49. Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1.
De Jesus M; Park CG; Su Y; Goldman DL; Steinman RM; Casadevall A
Med Mycol; 2008 Mar; 46(2):153-62. PubMed ID: 18324494
[TBL] [Abstract][Full Text] [Related]
50. 4-1BB-Based CAR T Cells Effectively Reverse Exhaustion and Enhance the Anti-Tumor Immune Response through Autocrine PD-L1 scFv Antibody.
Cheng K; Feng X; Chai Z; Wang Z; Liu Z; Yan Z; Wang Y; Zhang S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835603
[TBL] [Abstract][Full Text] [Related]
51. Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains.
Lam N; Trinklein ND; Buelow B; Patterson GH; Ojha N; Kochenderfer JN
Nat Commun; 2020 Jan; 11(1):283. PubMed ID: 31941907
[TBL] [Abstract][Full Text] [Related]
52. Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil.
Dal Pupo HD; Sena BAG; Reis FCG; Machado L; Fortes ST; de Almeida Junior JN; Godinho RMC; Rodrigues ML
Fungal Biol; 2019 Oct; 123(10):699-708. PubMed ID: 31542188
[TBL] [Abstract][Full Text] [Related]
53. PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
Jie Y; Liu G; Feng L; Li Y; E M; Wu L; Li Y; Rong G; Li Y; Wei H; Gu A
Front Immunol; 2021; 12():665970. PubMed ID: 34475869
[TBL] [Abstract][Full Text] [Related]
54. Insight into the Assembling Mechanism of
Fu Y; Huang X; Zhou Z
ACS Omega; 2020 Nov; 5(45):29351-29356. PubMed ID: 33225166
[No Abstract] [Full Text] [Related]
55. Isolation and purification of antigenic components of Cryptococcus.
Wozniak KL; Levitz SM
Methods Mol Biol; 2009; 470():71-83. PubMed ID: 19089377
[TBL] [Abstract][Full Text] [Related]
56. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
Drent E; Poels R; Ruiter R; van de Donk NWCJ; Zweegman S; Yuan H; de Bruijn J; Sadelain M; Lokhorst HM; Groen RWJ; Mutis T; Themeli M
Clin Cancer Res; 2019 Jul; 25(13):4014-4025. PubMed ID: 30979735
[TBL] [Abstract][Full Text] [Related]
57. A Novel Protocol for the Isolation of Fungal Extracellular Vesicles Reveals the Participation of a Putative Scramblase in Polysaccharide Export and Capsule Construction in
Reis FCG; Borges BS; Jozefowicz LJ; Sena BAG; Garcia AWA; Medeiros LC; Martins ST; Honorato L; Schrank A; Vainstein MH; Kmetzsch L; Nimrichter L; Alves LR; Staats CC; Rodrigues ML
mSphere; 2019 Mar; 4(2):. PubMed ID: 30894430
[TBL] [Abstract][Full Text] [Related]
58. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.
Retini C; Kozel TR; Pietrella D; Monari C; Bistoni F; Vecchiarelli A
Infect Immun; 2001 Oct; 69(10):6064-73. PubMed ID: 11553544
[TBL] [Abstract][Full Text] [Related]
59. Protein-polysaccharide interactions. A monoclonal antibody specific for the capsular polysaccharide of Cryptococcus neoformans.
Otteson EW; Welch WH; Kozel TR
J Biol Chem; 1994 Jan; 269(3):1858-64. PubMed ID: 8294434
[TBL] [Abstract][Full Text] [Related]
60. The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen.
Sundstrom JB; Cherniak R
Infect Immun; 1992 Oct; 60(10):4080-7. PubMed ID: 1398921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
